Newer macrolides as empiric treatment for acute Q fever infection.

Gikas, A; Kofteridis, D P; Manios, A; Pediaditis, J; Tselentis, Y

Gikas, A; Kofteridis, D P; Manios, A; Pediaditis, J; Tselentis, Y.

Afiliação

Gikas A; Zoonoses and Clinical Bacteriology, Parasitology, Geographical Medicine, and Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece. gikas@med.uoc.gr

Antimicrob Agents Chemother ; 45(12): 3644-6, 2001 Dec.

Article em En | MEDLINE | ID: mdl-11709360

ABSTRACT

ABSTRACT

The effectiveness of newer macrolides in acute Q fever for 113 patients was recorded. The mean times to defervescence were 2.9 days for doxycycline and 3.3, 3.9, 3.9, and 6.4 days for clarithromycin, roxithromycin, erythromycin, and beta-lactams, respectively (P < 0.01 for macrolides versus beta-lactams). We conclude that macrolides may be an adequate empirical antibiotic therapy for acute Q fever.

Assuntos

Antibacterianos/uso terapêutico; Febre Q/tratamento farmacológico; Doença Aguda; Adolescente; Adulto; Idoso; Anticorpos Antibacterianos/análise; Coxiella burnetii/efeitos dos fármacos; Feminino; Humanos; Lactamas; Macrolídeos; Masculino; Pessoa de Meia-Idade; Febre Q/diagnóstico; Febre Q/microbiologia; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Q / Antibacterianos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google